ATE98121T1 - Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie. - Google Patents

Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie.

Info

Publication number
ATE98121T1
ATE98121T1 AT90309638T AT90309638T ATE98121T1 AT E98121 T1 ATE98121 T1 AT E98121T1 AT 90309638 T AT90309638 T AT 90309638T AT 90309638 T AT90309638 T AT 90309638T AT E98121 T1 ATE98121 T1 AT E98121T1
Authority
AT
Austria
Prior art keywords
skin damage
radiotherapy
prevention
treatment
fatty acids
Prior art date
Application number
AT90309638T
Other languages
English (en)
Inventor
David Frederick Horrobin
Catherine Ann Scott
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10662681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE98121(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Application granted granted Critical
Publication of ATE98121T1 publication Critical patent/ATE98121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
  • Bipolar Transistors (AREA)
AT90309638T 1989-09-07 1990-09-04 Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie. ATE98121T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898920228A GB8920228D0 (en) 1989-09-07 1989-09-07 Fatty acid therapy

Publications (1)

Publication Number Publication Date
ATE98121T1 true ATE98121T1 (de) 1993-12-15

Family

ID=10662681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90309638T ATE98121T1 (de) 1989-09-07 1990-09-04 Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie.

Country Status (14)

Country Link
EP (1) EP0416855B1 (de)
JP (1) JPH0399013A (de)
KR (1) KR910005858A (de)
AT (1) ATE98121T1 (de)
AU (1) AU633618B2 (de)
CA (1) CA2024724A1 (de)
DE (1) DE69005062T2 (de)
DK (1) DK0416855T3 (de)
FI (1) FI904403A0 (de)
GB (1) GB8920228D0 (de)
HK (1) HK74694A (de)
IE (1) IE63449B1 (de)
NZ (1) NZ235203A (de)
ZA (1) ZA907040B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301446D0 (en) * 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
GB9621373D0 (en) * 1996-10-14 1996-12-04 Scotia Holdings Plc Fatty acid treatment
CA2278123A1 (en) * 1997-01-24 1998-07-30 Karen Hanley Use of fxr, ppar.alpha. and lxr.alpha. activators to restore barrier function, promote epidermal differentiation and inhibit proliferation
US5855893A (en) * 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
FR2765482B1 (fr) * 1997-07-07 2000-12-08 Oreal Utilisation de l'acide y-linolenique pour prevenir le stress oxydatif
GB9724802D0 (en) * 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
US9006287B2 (en) 2005-02-14 2015-04-14 Suntory Holdings Limited Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9682055B2 (en) 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205076A (en) * 1982-08-09 1985-04-30 Univ California Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
EP0309086A1 (de) * 1987-09-07 1989-03-29 Efamol Holdings Plc Behandlung der männlichen Glatze und von unerwünschtem Haarwuchs
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions

Also Published As

Publication number Publication date
IE63449B1 (en) 1995-04-19
HK74694A (en) 1994-08-05
KR910005858A (ko) 1991-04-27
EP0416855A2 (de) 1991-03-13
EP0416855B1 (de) 1993-12-08
IE903221A1 (en) 1991-03-13
FI904403A0 (fi) 1990-09-06
AU6213590A (en) 1991-03-14
JPH0399013A (ja) 1991-04-24
EP0416855A3 (en) 1991-06-12
DE69005062T2 (de) 1994-05-05
DK0416855T3 (da) 1994-02-14
NZ235203A (en) 1997-06-24
GB8920228D0 (en) 1989-10-18
AU633618B2 (en) 1993-02-04
ZA907040B (en) 1991-06-26
CA2024724A1 (en) 1991-03-08
DE69005062D1 (de) 1994-01-20

Similar Documents

Publication Publication Date Title
ATE98121T1 (de) Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie.
HUT65754A (en) Process for production of preparations containing complement inhibitors for treatment of inflammatory intestinal-and dermal-diseases
DE3881299D1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
SE8703625D0 (sv) New medical use
ATE163913T1 (de) Ungesättigte aliphatische dicarbonsäuren
DE69312579T2 (de) Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit
GR79989B (de)
DE69636085D1 (de) Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea
DE68917219D1 (de) Therapeutisches Erzeugnis zur Behandlung von Beschwerden während der oder nach den Wechseljahren.
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
EP0502925A4 (en) Method and composition for treating inflammatory bowel disorders
DE3886592D1 (de) Präparate zur Behandlung von Beschwerden der Wurzelhaut der Zähne.
ATE228835T1 (de) Verwendung von ranitidin-wismut-zitrat in kombination mit claritromyzin oder claritromyzin und tetrazyklin zur herstellung eines arzneimittels zur behandlung gastrointestinaler beschwerden
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE60508T1 (de) Eisen enthaltende zusammensetzung und verfahren zur behandlung von krebs.
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
DE3685052D1 (de) Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
DK0409559T3 (da) Farmaceutisk og diætetisk anvendelse af fedtsyrer
DE3681656D1 (de) Verwendung von linol- oder linolensaeure-metaboliten zur behandlung vom praemenstruellen syndrom.
DE3784738D1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3875637D1 (de) Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
SU1138167A1 (ru) Способ лечени асептических послеоперационных ран

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked